Peptide supply chain: difference between revisions
Diff·revision 3 → 4·05:12, 22 Oct 2024
Difference between revision 3 and revision 4 of Peptide supply chain. 12 lines changed; the page grew by 1,260 bytes.
| Revision 3 — 11:53, 15 Oct 2024 Ref_Desk_Ron (talk) rm a duplicated category 1,378 bytes ±0 | Revision 4 — 05:12, 22 Oct 2024 CDMO_Caradoc (talk) add the reconstitution-stability sentence with its storage condition 2,638 bytes +1,260 | ||
|---|---|---|---|
| 7 | Each operation has a characteristic failure mode, and the great majority of quality observations made downstream are attributable to one of them rather than to a general property of the material or the seller.{{r|gmp}} Knowing which stage produces which observation is what allows a purchaser to read a [[Certificate of analysis|certificate]] as evidence about something rather than as a number. | 7 | Each operation has a characteristic failure mode, and the great majority of quality observations made downstream are attributable to one of them rather than to a general property of the material or the seller.{{r|gmp}} Knowing which stage produces which observation is what allows a purchaser to read a [[Certificate of analysis|certificate]] as evidence about something rather than as a number. |
| 8 | 8 | ||
| + | 9 | == The stages and what each can go wrong at == | |
| + | 10 | | Stage | What happens | Characteristic failure mode | Visible in | | |
| + | 11 | |---|---|---|---| | |
| + | 12 | | Synthesis | Residues coupled one at a time on a solid support | Deletion sequences from incomplete coupling | Related-substance peaks close to the main peak | | |
| + | 13 | | Cleavage | Peptide released from resin, side chains deprotected | Incomplete deprotection; scavenger adducts | Mass spectrometry; not always in ultraviolet | | |
| + | 14 | | Purification | Preparative reverse-phase chromatography | Collection window too wide; co-eluting species carried through | [[Area percent purity]] on a shallower analytical gradient | | |
| + | 15 | | Counterion exchange | Trifluoroacetate exchanged, or not | Counterion left in place and unreported | [[Peptide content]]; ion chromatography | | |
| + | 16 | | Lyophilisation | Frozen solution dried under vacuum | Collapse; high residual moisture | Cake appearance; [[Karl Fischer titration]] | | |
| + | 17 | | Fill and finish | Solution or powder into vials, stoppered, crimped | Fill variation; closure integrity | Weight check; appearance on reconstitution | | |
| + | 18 | | Freight and storage | Transport, customs, warehousing | [[Temperature excursion]]; undocumented storage interval | Nothing on the certificate | | |
| + | 19 | ||
| 9 | == References == | 20 | == References == |
| 10 | {{reflist}} | 21 | {{reflist}} |
| ⋮ | ⋮ | ||
| 15 | [[Category:Peptide synthesis]] | 26 | [[Category:Peptide synthesis]] |
| 16 | [[Category:Supply chain integrity]] | 27 | [[Category:Supply chain integrity]] |
| + | 28 | [[Category:Manufacturing and supply]] | |
| 17 | 29 |